New Results

Compound biological signatures facilitate phenotypic screening and target elucidation

Alvaro Cortes Cabrera, Daniel Lucena-Agell, Mariano Redondo-Horcajo, Isabel Barasoain, Fernando Diaz, Bernhard Fasching, Paula Petrone
doi: https://doi.org/10.1101/041947

Article Information

doi 
https://doi.org/10.1101/041947
History 
  • March 2, 2016.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Alvaro Cortes Cabrera1,
  2. Daniel Lucena-Agell2,
  3. Mariano Redondo-Horcajo2,
  4. Isabel Barasoain2,
  5. Fernando Diaz2,
  6. Bernhard Fasching3 and
  7. Paula Petrone1
  1. 1Pharma Research & Early Development Informatics (pREDi). Roche Innovation Center Basel, Basel, Switzerland.
  2. 2Laboratory of microtubule stabilizing agents. Department of Physico-chemical Biology. Center for Biological Research. CSIC. Madrid. Spain.
  3. 3Medicinal Chemistry. Pharma Research & Early Development (pRED). Roche Innovation Center Basel, Basel, Switzerland.
Back to top
Posted March 02, 2016.
Download PDF

Supplementary Material

Email
Compound biological signatures facilitate phenotypic screening and target elucidation
Alvaro Cortes Cabrera, Daniel Lucena-Agell, Mariano Redondo-Horcajo, Isabel Barasoain, Fernando Diaz, Bernhard Fasching, Paula Petrone
bioRxiv 041947; doi: https://doi.org/10.1101/041947
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area